BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 3, 2014
View Archived Issues
Merz signs agreement with Brickell Biotech for novel retinoid therapy
Read More
China's regulatory authority approves phase II trials of F-351
Read More
Transcept Pharmaceuticals and Paratek Pharmaceuticals to merge
Read More
Pharmacodynamic effects of AZD-3241 revealed in PD patients
Read More
Osteogenesis improved in patients with hypophosphatasia
Read More
Johnson & Johnson completes divestiture of Ortho-Clinical Diagnostics
Read More
FOXO1 as a potential therapeutic target for diabetes demonstrated with AS-1842856
Read More
Vertex Pharmaceuticals discloses new ATR inhibitors for cancer
Read More
New CB2 receptor agonists patented by Roche
Read More
Allergan obtains FDA approval for Ozurdex and updates progress of key programs
Read More
Roche designs new SCD inhibitors for cancer
Read More
Agenus reports final results from phase II study of Prophage in newly diagnosed GBM
Read More
Rigel Pharmaceuticals divulges novel PKC inhibitors for ocular disorders
Read More
Researchers in the U.S. and China disclose new agents for cancer and other disorders
Read More
Genocea discloses 12-month follow-up data from phase I/IIa trial of HSV vaccine
Read More
Boston Strategics forms licensing deal with Eisai for E-6201
Read More
Scientists at Pierre Fabre design novel NMDA receptor antagonists
Read More
Synageva BioPharma reports topline data from phase III study of sebelipase alfa
Read More
Phase I first-in-human study begins for GLPG-1690
Read More
Insys Therapeutics receives FDA orphan drug designation for CBD
Read More
Genentech to acquire Seragon Pharmaceuticals
Read More
Oncoceutics presents preclinical data on lead compound
Read More
FDA grants priority review to nintedanib NDA for IPF
Read More
Taiho Pharmaceutical seeks additional indication approval in Japan for Zosyn
Read More
Rifaximin achieves endpoint in phase III trial in IBS with diarrhea
Read More
Boehringer Ingelheim files MAAs for tiotropium/olodaterol combination in Europe
Read More
Actavis completes Furiex acquisition
Read More
Pozen resubmits aspirin/omeprazole NDAs to the FDA
Read More